Marginal-Zone Lymphomas
Marginal-Zone Lymphomas
About this item
Full title
Marginal-Zone Lymphomas
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2022-02, Vol.386 (6), p.568-581
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
The third most common lymphoma, MZL is usually indolent and often a consequence of chronic antigenic stimulation from a pathogen such as
Helicobacter pylori
or hepatitis C virus. Some MZLs regress with treatment of the infection. Patients with genetic lesions are treated with chemoimmunotherapy.
Alternative Titles
Full title
Marginal-Zone Lymphomas
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2627480342
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2627480342
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMra2102568
